Is management of MDR-/XDR-TB in Europe adequate? A TBNET survey
A. Facchini, L. D‘Ambrosio, G. Sotgiu, G. Guenther, J. P. Zellweger, G. Bothamley, R. Centis, R. Muetterlein, S. De Lorenzo, M. Villar, K. Kliiman, V. Spinu, C. Lange, D. Manissero, G. B. Migliori, TBNET Tuberculosis Network European Trialsgroup (Tradate, Sassari, Sondalo, Italy; , Germany; Berne, Switzerland; London, United Kingdom; Lisbon, Portugal; Tartu, Estonia; Bucharest, Romania; Stockholm, Sweden)
Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Facchini, L. D‘Ambrosio, G. Sotgiu, G. Guenther, J. P. Zellweger, G. Bothamley, R. Centis, R. Muetterlein, S. De Lorenzo, M. Villar, K. Kliiman, V. Spinu, C. Lange, D. Manissero, G. B. Migliori, TBNET Tuberculosis Network European Trialsgroup (Tradate, Sassari, Sondalo, Italy; , Germany; Berne, Switzerland; London, United Kingdom; Lisbon, Portugal; Tartu, Estonia; Bucharest, Romania; Stockholm, Sweden). Is management of MDR-/XDR-TB in Europe adequate? A TBNET survey. Eur Respir J 2010; 36: Suppl. 54, 349
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: